XENE Q2 2025 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$632,000

Operating Income

-$94M

Net Income

-$85M

EPS (Diluted)

$-1.07

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$64M

Free Cash Flow

-$64M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$674M

Total Liabilities

$40M

Stockholders' Equity

$634M

Cash & Equivalents

$135M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$632,000	$0	—
Operating Income	-$94M	-$69M	-36.4%
Net Income	-$85M	-$58M	-46.2%